A new study suggests that psilocybin, the active compound in magic mushrooms, may be a viable alternative to traditional antidepressants. Researchers found that a single dose of psilocybin was just as effective as a six-week course of escitalopram (Lexapro) in reducing depression symptoms, with additional benefits for overall well-being.
A new study published in JAMA Network Open explores how cannabis legalization, both medical and recreational, is affecting the prescription of mental health medications in the U.S. The findings reveal a complex relationship, with cannabis laws leading to both decreased benzodiazepine prescriptions and increased use of antidepressants and antipsychotics. This underscores the need for further research into the broader impact of cannabis legalization on mental health treatment.
